Delivery Order SPE2DB20D7066-SPE2DB26FC1MW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,517.14 to AmerisourceBergen Drug Corp for Vasostrict (vasopressin) 20 unit/mL vials, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract utilizing the company's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vasostrict (vasopressin) 20 unit/mL vials on November 10, 2025, with a ceiling value of $1,525.38 and ultimate completion date of November 12, 2025. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,168.50 to AmerisourceBergen Drug Corp for Vasostrict 20 unit/mL vials on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a small-value pharmaceutical procurement for the federal government's medical supply chain. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,048.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vasostrict 20 Unit/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was issued on September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product is a vasopressor medication used primarily in military and federal healthcare settings to support critical care operations. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Vasostrict 20 unit/mL vials valued at $1,947.50 on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,168.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vasostrict 20 Unit/mL vials. This non-competitive delivery order, with an ultimate completion date of July 29, 2025, will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected to deliver this critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vasostrict 20 Unit/mL vials, valued at $1,168.50 with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract performed from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle extending...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $5,183.75 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply twenty units of Vasostrict, a vasopressin injection product, for distribution to military treatment facilities. The single delivery will take place from Amerisourcebergen's distribution center in Conshohocken, Pennsylvania on July 19, 2023. No subcontractors or set-aside designations were...
- The Defense Logistics Agency Troop Support Medical awarded a $672.61 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 unit/ml vials of Vasostrict. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The period of performance is July 6-7, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,656 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4562125883 units of Vasostrict, a vasopressin injection product, to a Defense Logistics Agency location in Conshohocken, Pennsylvania. Performance is required from September 11-12, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen regularly supports the Defense...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1MWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,168.50 to AmerisourceBergen Drug Corp for Vasostrict (vasopressin) 20 unit/mL vials on October 31, 2025, with completion scheduled for November 3, 2025. This firm fixed-price contract, which involved no set-aside designation, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value order within the scope of AmerisourceBergen's broader federal pharmaceutical supply mission. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a prime vendor for military healthcare systems, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare programs worldwide. The IDC structure allows for flexible ordering of critical medications across multiple therapeutic domains, with this specific order for Vasostrict—a vasopressor medication used in acute medical and surgical settings—exemplifying the company's role in ensuring continuous availability of essential pharmaceutical commodities for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/31/25 |